Case Study: Leading Pharmaceutical Company enhances cancer drug insights with Quantzig real world evidence analytics

Impact of Real World Evidence Analytics in the New Cancer Drugs Segment

Leading Pharmaceutical Company, a U.S.-based pharmaceutical player focused on discovering, developing, and commercializing novel cancer drugs, was struggling to compare the cost and outcomes of its products. Its previous analysis was limited to clinical outcomes because it lacked the ability to use real world data and had insufficient analytics capacity and skills. The company turned to Quantzig for real world evidence analytics support.

Quantzig leveraged real world data sources and advanced analytics techniques to build the foundation for a deeper analysis of new cancer drug development pathways and patient cohorts. As a result, the client gained broadened analytic capabilities, enhanced insights to guide future business value, and self-service analytic skills. While no specific numerical impact was disclosed, Quantzig helped the company move beyond clinical-only analysis toward a more data-driven drug development approach.